Outcome Disparities in Caucasian and non-Caucasian Patients with Myeloproliferative Neoplasms

Conclusion This study shows for the first time that race can influence clinical outcomes in myeloproliferative neoplasms. This study highlights the need for greater representation of non-Caucasian patients in studies investigating vascular risk factors in MPNs. Teaser This is a single institution retrospective experience examining the effect of race and ethnicity on disease phenotype in myeloproliferative neoplasms. We demonstrate racial disparities in the outcomes of myeloproliferative neoplasm with Caucasian ethnicities being relatively protected against cardiovascular thrombosisis and hemorrhagic complications. African Americans are the ethnic sub-group at highest risk of hemorrhagic complications.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research